Keywords: sanofi-aventis, 3rd-qtr, sales, rise, recently-formed, french, drugmaker
Sanofi-Aventis' 3rd-qtr sales rise 10.7%
Article | 01 November 2004
Recently-formed French drugmaker Sanofi-Aventis saw its third-quarter pro forma combined revenues climb 10.7% to 6.5 billion euros ($8.1 billion), as the group reported ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
